The Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand (PREDICT) clinical trial, which enrolled HIV-positive children aged 1–12 years, showed high AIDS-free survival in both early (CD4 15–24%) and deferred ART (CD4 <15%) groups [9]. This evidence concerns the gene CD4 and AIDS.